Quarterly report · Q1
4548.TEDINET S100RLV9
Period2023-04-01 → 2023-06-30
Filed2023-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥9.7bn | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥33.5bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.3bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥1.3bn | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥1.1bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥2.0bn | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥3.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.7bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.0bn | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.7bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.9bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.2bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.5bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.9bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥1.5bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥77.1bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥75.6bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥75.0bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.5bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥8.4bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥69.6bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥67.2bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥67.3bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥20.3bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥23.5bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥34.62 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥40.49 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥26.62 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 90.3% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.9% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.8% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q1r_E00970-000LALreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥2.5bn |
| jpcrp040300-q1r_E00970-000LALreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥2.5bn |
| jpcrp040300-q1r_E00970-000LALreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥327m |
| jpcrp040300-q1r_E00970-000Pharmaceuticalreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥7.2bn |
| jpcrp040300-q1r_E00970-000Pharmaceuticalreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥7.2bn |
| jpcrp040300-q1r_E00970-000Pharmaceuticalreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥971m |
| —segment total | revenue | 2023-04-01 → 2023-06-30 | ¥9.7bn |
| —segment total | revenue external | 2023-04-01 → 2023-06-30 | ¥9.7bn |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | ¥1.3bn |
| jpcrp040300-q1r_E00970-000LALreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥2.8bn |
| jpcrp040300-q1r_E00970-000LALreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥2.8bn |
| jpcrp040300-q1r_E00970-000LALreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥899m |
| jpcrp040300-q1r_E00970-000Pharmaceuticalreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥5.5bn |
| jpcrp040300-q1r_E00970-000Pharmaceuticalreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥5.5bn |
| jpcrp040300-q1r_E00970-000Pharmaceuticalreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥227m |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥8.3bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥8.3bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥1.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 382
| Item | Context | Value | Unit |
|---|---|---|---|
| Noncurrent liabilities | Prior1YearInstant | 1709000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 2116000000 | JPY |
| Liabilities | Prior1YearInstant | 8408000000 | JPY |
| Liabilities | CurrentQuarterInstant | 7511000000 | JPY |
| Capital stock | Prior1YearInstant | 3840000000 | JPY |
| Capital stock | CurrentQuarterInstant | 3840000000 | JPY |
| Capital surplus | Prior1YearInstant | 5301000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 5301000000 | JPY |
| Retained earnings | Prior1YearInstant | 53975000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 55154000000 | JPY |
| Treasury stock | Prior1YearInstant | -2279000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -2279000000 | JPY |
| Shareholders equity | Prior1YearInstant | 60837000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 62016000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 3033000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 4057000000 | JPY |
| Deferred gains or losses on hedges | Prior1YearInstant | -14000000 | JPY |
| Deferred gains or losses on hedges | CurrentQuarterInstant | - | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 2937000000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 3081000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 423000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 399000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 6379000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 7539000000 | JPY |
| Net assets | Prior1YearInstant | 67216000000 | JPY |
| Net assets | CurrentQuarterInstant | 69555000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 75625000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 77067000000 | JPY |
| Net sales | Prior1YTDDuration | 8307000000 | JPY |
| Net sales | CurrentYTDDuration | 9661000000 | JPY |
| Cost of sales | Prior1YTDDuration | 3622000000 | JPY |
| Cost of sales | CurrentYTDDuration | 4477000000 | JPY |
| Gross profit | Prior1YTDDuration | 4684000000 | JPY |
| Gross profit | CurrentYTDDuration | 5183000000 | JPY |
| Personal expenses sga | Prior1YTDDuration | 680000000 | JPY |
| Personal expenses sga | CurrentYTDDuration | 780000000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 89000000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 83000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 26000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 25000000 | JPY |
| Research and development expenses sga | Prior1YTDDuration | 1687000000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 1738000000 | JPY |
| Other sga | Prior1YTDDuration | 1074000000 | JPY |
| Other sga | CurrentYTDDuration | 1257000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 3558000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 3885000000 | JPY |
| Operating income | Prior1YTDDuration | 1126000000 | JPY |
| Operating income | CurrentYTDDuration | 1298000000 | JPY |
| Interest income noi | Prior1YTDDuration | 5000000 | JPY |
| Interest income noi | CurrentYTDDuration | 29000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |